Goldenwell Biotech, Inc. (GWLL)
GWLL Stock Price Chart
Explore Goldenwell Biotech, Inc. interactive price chart. Choose custom timeframes to analyze GWLL price movements and trends.
GWLL Company Profile
Discover essential business fundamentals and corporate details for Goldenwell Biotech, Inc. (GWLL) to support your stock research and investment decisions.
Sector
Consumer Defensive
Industry
Packaged Foods
IPO Date
30 Sept 2022
Employees
3.00
CEO
Shuang Liu
Description
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as DNA repair tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
GWLL Financial Timeline
Browse a chronological timeline of Goldenwell Biotech, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
GWLL Stock Performance
Access detailed GWLL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.